NO20024906D0 - Antitumorale ekteinascidinderivater - Google Patents

Antitumorale ekteinascidinderivater

Info

Publication number
NO20024906D0
NO20024906D0 NO20024906A NO20024906A NO20024906D0 NO 20024906 D0 NO20024906 D0 NO 20024906D0 NO 20024906 A NO20024906 A NO 20024906A NO 20024906 A NO20024906 A NO 20024906A NO 20024906 D0 NO20024906 D0 NO 20024906D0
Authority
NO
Norway
Prior art keywords
sub
dbd
alkyl
alkynyl
alkenyl
Prior art date
Application number
NO20024906A
Other languages
English (en)
Other versions
NO329125B1 (no
NO20024906L (no
Inventor
Maria Flores
Andres Francesch
Pilar Gallego
Jose Luis Chicharro
Maria Zarzuelo
Carolina Fernandez
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009043A external-priority patent/GB0009043D0/en
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Priority claimed from GB0022644A external-priority patent/GB0022644D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20024906D0 publication Critical patent/NO20024906D0/no
Publication of NO20024906L publication Critical patent/NO20024906L/no
Publication of NO329125B1 publication Critical patent/NO329125B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20024906A 2000-04-12 2002-10-11 Ecteinascidinderivater, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eventuelt i kombinasjon med andre legemidler ved fremstilling av farmsoytiske preparater for behandling av tumorer NO329125B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0009043A GB0009043D0 (en) 2000-04-12 2000-04-12 New autitumoural derivatives of ET-743
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
GB0022644A GB0022644D0 (en) 2000-09-14 2000-09-14 Antitumoral derivatives of ET-743
PCT/GB2001/001667 WO2001077115A1 (en) 2000-04-12 2001-04-12 Antitumoral ecteinascidin derivatives

Publications (3)

Publication Number Publication Date
NO20024906D0 true NO20024906D0 (no) 2002-10-11
NO20024906L NO20024906L (no) 2002-11-27
NO329125B1 NO329125B1 (no) 2010-08-30

Family

ID=26244092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024906A NO329125B1 (no) 2000-04-12 2002-10-11 Ecteinascidinderivater, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eventuelt i kombinasjon med andre legemidler ved fremstilling av farmsoytiske preparater for behandling av tumorer

Country Status (27)

Country Link
US (1) US7202361B2 (no)
EP (1) EP1280809B1 (no)
JP (1) JP5219323B2 (no)
KR (1) KR100886496B1 (no)
CN (1) CN1436191B (no)
AR (1) AR032879A1 (no)
AT (1) ATE299146T1 (no)
AU (1) AU784249C (no)
BG (1) BG65987B1 (no)
BR (1) BRPI0110024B8 (no)
CA (1) CA2406080C (no)
CZ (1) CZ304749B6 (no)
DE (1) DE60111845T2 (no)
DK (1) DK1280809T3 (no)
EA (1) EA006206B1 (no)
ES (1) ES2244598T3 (no)
HK (1) HK1049005B (no)
HU (1) HU230918B1 (no)
IL (1) IL152094A (no)
MX (1) MXPA02010088A (no)
NO (1) NO329125B1 (no)
NZ (1) NZ521550A (no)
PL (1) PL210703B1 (no)
PT (1) PT1280809E (no)
SI (1) SI1280809T1 (no)
SK (1) SK288017B6 (no)
WO (1) WO2001077115A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058125A1 (en) 1998-05-11 1999-11-18 Pharma Mar, S.A. Metabolites of ecteinascidin 743
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
EP1435988A4 (en) * 2001-10-19 2008-01-09 Pharmamar Sa IMPROVED USE OF ANTI-TUMORAL COMPOUND IN THE TREATMENT OF CANCER
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
EP1689404B9 (en) 2003-11-13 2009-04-22 Pharma Mar, S.A.U. Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer
US20080242670A2 (en) * 2004-09-29 2008-10-02 Pharma Mar S.A., Sociedad Unipersonal Anti-Inflammatory Agents
RU2382647C2 (ru) 2004-10-29 2010-02-27 Фарма Мар С.А., Сосьедад Униперсональ Композиции, содержащие эктинэсайдин и дисахарид
US8067462B2 (en) * 2004-12-20 2011-11-29 The Trustees Of Columbia University In The City Of New York Processes of making sesquiterpenoid tashironin, its analogs and their uses
US20090131498A1 (en) * 2005-01-18 2009-05-21 Danishefsky Samuel J Enantioselective Synthesis of Merrilactone and Its Analogs
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
WO2007087220A2 (en) * 2006-01-25 2007-08-02 The Trustees Of Columbia University In The City Of New York The total synthesis of ecteinascidin 743 and derivatives thereof
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
ES2534331T3 (es) 2010-05-25 2015-04-21 Pharma Mar S.A. Proceso sintético para la producción de compuestos e intermedios de ecteinascidina
HUE049389T2 (hu) 2010-11-12 2020-09-28 Pharma Mar Sa Kombinált terápia topoizomeráz inhibitorral
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112679513B (zh) * 2019-10-18 2023-08-25 南通诺泰生物医药技术有限公司 一种制备曲贝替定的关键中间体的方法
CN114940682A (zh) * 2022-05-18 2022-08-26 博瑞制药(苏州)有限公司 芦比替定的晶型及其制备方法和用途
CN115677728A (zh) * 2022-11-02 2023-02-03 成都科岭源医药技术有限公司 一种海鞘素类化合物中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5256663A (en) 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5089273A (en) 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
EP0309477B1 (en) 1986-06-09 1991-11-06 The Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5478932A (en) 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
WO1999058125A1 (en) 1998-05-11 1999-11-18 Pharma Mar, S.A. Metabolites of ecteinascidin 743
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US6686470B2 (en) 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
ATE299146T1 (de) 2005-07-15
SI1280809T1 (sl) 2005-12-31
IL152094A0 (en) 2003-05-29
AR032879A1 (es) 2003-12-03
US7202361B2 (en) 2007-04-10
HU230918B1 (hu) 2019-03-28
KR20030012864A (ko) 2003-02-12
BRPI0110024B8 (pt) 2021-05-25
CA2406080A1 (en) 2001-10-18
AU784249B2 (en) 2006-02-23
HK1049005A1 (en) 2003-04-25
KR100886496B1 (ko) 2009-03-05
DE60111845D1 (de) 2005-08-11
BRPI0110024B1 (pt) 2019-07-16
JP2003530402A (ja) 2003-10-14
HUP0300534A2 (hu) 2003-07-28
AU784249C (en) 2007-05-03
NZ521550A (en) 2004-10-29
ES2244598T3 (es) 2005-12-16
IL152094A (en) 2011-10-31
EA006206B1 (ru) 2005-10-27
DE60111845T2 (de) 2006-04-27
BG65987B1 (bg) 2010-08-31
BG107220A (en) 2003-05-30
CN1436191B (zh) 2011-09-14
US20030216397A1 (en) 2003-11-20
NO329125B1 (no) 2010-08-30
DK1280809T3 (da) 2005-11-07
SK14352002A3 (sk) 2003-04-01
JP5219323B2 (ja) 2013-06-26
EA200201083A1 (ru) 2003-04-24
HK1049005B (zh) 2006-01-27
EP1280809A1 (en) 2003-02-05
CZ20023352A3 (cs) 2003-05-14
SK288017B6 (sk) 2012-11-05
BR0110024A (pt) 2003-02-18
CN1436193A (zh) 2003-08-13
EP1280809B1 (en) 2005-07-06
WO2001077115A1 (en) 2001-10-18
NO20024906L (no) 2002-11-27
MXPA02010088A (es) 2004-08-19
CZ304749B6 (cs) 2014-09-24
AU4672901A (en) 2001-10-23
HUP0300534A3 (en) 2006-02-28
CA2406080C (en) 2011-11-29
PL357574A1 (en) 2004-07-26
PT1280809E (pt) 2005-11-30
PL210703B1 (pl) 2012-02-29

Similar Documents

Publication Publication Date Title
NO20024906D0 (no) Antitumorale ekteinascidinderivater
EP1254659A4 (en) STABLE EMULSION PREPARATIONS
TWI266761B (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
DE69418704T2 (de) Anthranilsäure derivate
ATE444279T1 (de) Modulatoren von cannabinoidrezeptoren
HRP20031098B1 (en) Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
NZ518144A (en) Piperazine Compounds
EP0776884A4 (en) SUBSTITUTED AMID DERIVATIVES
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
TW200716084A (en) Methods for treating sleep-wake disorders
TW200727893A (en) Methods for treating sexual dysfunction
FI931763A0 (fi) 4,1-bensoxazepinderivat och deras anvaendning
ATE88714T1 (de) 2'-desoxy-5-fluoruridinderivate.
MXPA04001240A (es) Analogos antitumorales.
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
MXPA05008706A (es) 4-[(2, 4- dicloro-5 -metoxifenil) amino]-6 -alcoxi -3- quinolincarbonitrilos para tratamiento de lesiones isquemicas.
YU5199A (sh) Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija
KR970069989A (ko) 피리딘-2,3-디카르복실산 디아미드 유도체 및 유효성분으로 상기 유도체를 함유하는 제초제
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
AU3894099A (en) Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
TW200626007A (en) Material for electroluminescent element and electroluminescent element
EP1219599A4 (en) VITAMIN-D DERIVATIVES WITH SUBSTITUENTS IN THE 2-ALPHA POSITION
WO2001081315A3 (en) Amino-imidazole derivatives for treating cancer

Legal Events

Date Code Title Description
MK1K Patent expired